-GRISTMedia.com In the course of my work as part of a team set up to look into the socio-economic status of Adivasi communities, there were several things I learned about the Land Acquisition Act, 2013, and the amendments to it. Here are some important questions about land and the Act that we should be asking: * What is the State's relationship to land and its citizens? This a key question - and one...

-PTI Kolkata: West Bengal's Nadia district is poised to complete building toilets for all its residents by next March, under a programme which has been shortlisted for the United Nations global award for public service. Nadia district magistrate P B Salim told PTI that 95 percent of the people had already stopped defecating in the open and by this March they would achieve a 100 percent open defecation-free status. His scheme "Sobar...

-Kafila.org With depressing regularity, the newspapers have been reporting farmers' suicides in many states. Recently, P Sainath wrote on BBC that around 296,438 farmers have committed suicide since 1995. He also mentions that cash crop cultivators of cotton, sugar cane, vanilla, pepper, groundnut etc account for the bulk of those suicides. According to a PIL heard by the Supreme Court in December 2014, around 3146 farmers in Maharashtra have committed suicide...

-Down to Earth The situation of India's farmers has only become grimmer in the past decade, according to the latest National Sample Survey Office report The lot of the embattled Indian farmer only keeps on getting worse with the passage of time. In the last 10 years, the voluminous debt of Indian agricultural households has increased almost four-fold whereas their undersized monthly income from cultivation has increased three-fold. Even the number of...

-The Telegraph New Delhi: India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine. The Indian Patents Controller has denied a patent to sofosbuvir from Gilead, a US biopharmaceutical company that had last year pledged to make the oral drug available in India and 90 other developing countries at $900...